Teclistamab plus daratumumab delivers unprecedented progression-free survival benefits over standard of care in ...
Early Intervention: Flagging non-adherence allows for earlier intervention, such as a phone call. This compassionate, ...
New research presented at ASCO GI positions both agents as potent therapeutic options, with potential to redefine standard ...
Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...
Influenza surveillance is essential to accurately measure disease burden, guide policy, and strengthen preparedness for ...
The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the ...
ICHRAs could either stabilize or destabilize ACA risk pools, with adoption patterns raising concerns about access, equity, ...
Steven Stoner, PharmD, advises managed care teams to use rigorous diagnostic assessments, monitor adherence, and invest ...
Adults with hypertension who have prediabetes and subclinical myocardial injury or stress face a higher risk of incident ...
Trump Terminates Hundreds of SAMHSA Grants, Threatening Mental Health, Addiction Services Nationwide
Approximately $2 billion in grants were canceled, undermining bipartisan efforts to strengthen the behavioral health system ...
Explore the latest findings from the KATHERINE, PATINA, and HER2CLIMB-05 trials, highlighting advancements and challenges in breast cancer treatment.
Presenters shared their personal highlights of attending ASCO GI 2026. The 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium showcased not only transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results